IP Library › Granted Patent US 9,409,970
Granted Patent B2
US 9,409,970 · App. 14/178,360 · Granted Aug 9, 2016

Polynucleotides encoding BSL2v2c2

Inventors: Glen Eugene Mikesell (Pacifica, CA); Han Chang (Princeton Junction, NJ); Joshua N. Finger (Spring City, PA); Guchen Yang (Princeton, NJ); Robert James Peach (San Diego, CA); Henry Shen (Princeton, NJ)
Assignee: Bristol-Myers Squibb Company
C07K14/70532A61K47/48369C07K16/2827A61K38/00C07K2317/56C07K2317/76C07K2319/00C07K2319/30Y10S435/81
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,409,970
App. No.
14/178,360
Granted
Aug 9, 2016
Kind
B2
Abstract

The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.

Claims (5)

1. An isolated polynucleotide comprising nucleotides encoding the extracellular domain of SEQ ID NO:13.

2. The isolated polynucleotide according to claim 1 wherein said extracellular domain comprises amino acids 1 to 246 of SEQ ID NO:13.

3. The isolated polynucleotide of claim 2 , wherein said polynucleotide comprises nucleotides 1 to 738 of SEQ ID NO:12.

4. An isolated polynucleotide comprising nucleotides encoding amino acids 2 to 246 of SEQ ID NO:13.

5. The isolated polynucleotide of claim 4 , wherein said polynucleotide comprises nucleotides 4 to 738 of SEQ ID NO:12.

Continuity (9)
Division 13331540 · Dec 20, 2011
Division 12701119 · Feb 5, 2010
Division 11900026 · Sep 6, 2007
Division 11355735 · Feb 16, 2006
Division 10994824 · Nov 22, 2004
Division 09875338 · Jun 6, 2001
Provisional Application 60272107 · Feb 28, 2001
Provisional Application 60209811 · Jun 6, 2000
Related Publication 20140194598A1 · Jul 10, 2014